Ochratoxin Immunoaffinity Columns (IAC) - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511248318

Publication Date:

November 5, 2024

Pages:

160

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Agriculture [2]

Industry & Manufacturing [3]

Description:

Ochratoxin Immunoaffinity Columns (IACs) are specialized chromatographic columns used for the extraction and purification of ochratoxins from various samples. Ochratoxins are a group of mycotoxins produced by molds, particularly species of Aspergillus and Penicillium. The most common and studied ochratoxin is ochratoxin A (OTA).
The global market for Ochratoxin Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Ochratoxin Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ochratoxin Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Ochratoxin Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Ochratoxin Immunoaffinity Columns (IAC) include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG and CHROMATIFIC, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ochratoxin Immunoaffinity Columns (IAC), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ochratoxin Immunoaffinity Columns (IAC) by region & country, by Type, and by Application.
The Ochratoxin Immunoaffinity Columns (IAC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ochratoxin Immunoaffinity Columns (IAC).
麻豆原创 Segmentation
By Company
Gold Standard Diagnostics Horsham
LCTech
Shimadzu
Biotez Berlin
PerkinElmer
VICAM
Ring Biotechnology
R-Biopharm AG
CHROMATIFIC
Neogen
Kwinbon Biotechnology
Shandong Meizheng Bio-Tech
Pribolab
Jiangsu Suwei Micro-Biology Research
Shandong Lvdu Bio-Sciences & Technology
Jiangsu Wisdom Engineering & Technology
BIOCOMMA
Beijing Nano-Ace Technology
Femdetection
Wuhan Huamei Wisherkon Biotech
Changsha Huaxue Biological Technology
Anavo
Shandong Vnya Bio-technology
Guanyibio
Prufunglab
Segment by Type:
80% Below
80-90%
91-100%
100% Above
Segment by Application
Grains
Feed
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ochratoxin Immunoaffinity Columns (IAC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ochratoxin Immunoaffinity Columns (IAC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ochratoxin Immunoaffinity Columns (IAC) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Ochratoxin Immunoaffinity Columns (IAC) Product Introduction
1.2 Global Ochratoxin Immunoaffinity Columns (IAC) 麻豆原创 Size Forecast
1.2.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value (2019-2030)
1.2.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume (2019-2030)
1.2.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Price (2019-2030)
1.3 Ochratoxin Immunoaffinity Columns (IAC) 麻豆原创 Trends & Drivers
1.3.1 Ochratoxin Immunoaffinity Columns (IAC) Industry Trends
1.3.2 Ochratoxin Immunoaffinity Columns (IAC) 麻豆原创 Drivers & Opportunity
1.3.3 Ochratoxin Immunoaffinity Columns (IAC) 麻豆原创 Challenges
1.3.4 Ochratoxin Immunoaffinity Columns (IAC) 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ochratoxin Immunoaffinity Columns (IAC) Players Revenue Ranking (2023)
2.2 Global Ochratoxin Immunoaffinity Columns (IAC) Revenue by Company (2019-2024)
2.3 Global Ochratoxin Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2023)
2.4 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Company Players (2019-2024)
2.5 Global Ochratoxin Immunoaffinity Columns (IAC) Average Price by Company (2019-2024)
2.6 Key Manufacturers Ochratoxin Immunoaffinity Columns (IAC) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ochratoxin Immunoaffinity Columns (IAC) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ochratoxin Immunoaffinity Columns (IAC)
2.9 Ochratoxin Immunoaffinity Columns (IAC) 麻豆原创 Competitive Analysis
2.9.1 Ochratoxin Immunoaffinity Columns (IAC) 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ochratoxin Immunoaffinity Columns (IAC) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ochratoxin Immunoaffinity Columns (IAC) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 80% Below
3.1.2 80-90%
3.1.3 91-100%
3.1.4 100% Above
3.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type
3.2.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value, by Type (2019-2030)
3.2.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value, by Type (%) (2019-2030)
3.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Type
3.3.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume, by Type (2019-2030)
3.3.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume, by Type (%) (2019-2030)
3.4 Global Ochratoxin Immunoaffinity Columns (IAC) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Grains
4.1.2 Feed
4.1.3 Others
4.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application
4.2.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value, by Application (2019-2030)
4.2.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value, by Application (%) (2019-2030)
4.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Application
4.3.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume, by Application (2019-2030)
4.3.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume, by Application (%) (2019-2030)
4.4 Global Ochratoxin Immunoaffinity Columns (IAC) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Region
5.1.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024)
5.1.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030)
5.1.4 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Region (%), (2019-2030)
5.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Region
5.2.1 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024)
5.2.3 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030)
5.2.4 Global Ochratoxin Immunoaffinity Columns (IAC) Sales Volume by Region (%), (2019-2030)
5.3 Global Ochratoxin Immunoaffinity Columns (IAC) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.4.2 North America Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.5.2 Europe Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.6.2 Asia Pacific Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.7.2 South America Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.8.2 Middle East & Africa Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ochratoxin Immunoaffinity Columns (IAC) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ochratoxin Immunoaffinity Columns (IAC) Sales Value
6.2.1 Key Countries/Regions Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ochratoxin Immunoaffinity Columns (IAC) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.3.2 United States Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.4.2 Europe Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.5.2 China Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.6.2 Japan Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.7.2 South Korea Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.8.2 Southeast Asia Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ochratoxin Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.9.2 India Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ochratoxin Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gold Standard Diagnostics Horsham
7.1.1 Gold Standard Diagnostics Horsham Company Information
7.1.2 Gold Standard Diagnostics Horsham Introduction and Business Overview
7.1.3 Gold Standard Diagnostics Horsham Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gold Standard Diagnostics Horsham Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.1.5 Gold Standard Diagnostics Horsham Recent Development
7.2 LCTech
7.2.1 LCTech Company Information
7.2.2 LCTech Introduction and Business Overview
7.2.3 LCTech Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 LCTech Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.2.5 LCTech Recent Development
7.3 Shimadzu
7.3.1 Shimadzu Company Information
7.3.2 Shimadzu Introduction and Business Overview
7.3.3 Shimadzu Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shimadzu Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.3.5 Shimadzu Recent Development
7.4 Biotez Berlin
7.4.1 Biotez Berlin Company Information
7.4.2 Biotez Berlin Introduction and Business Overview
7.4.3 Biotez Berlin Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biotez Berlin Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.4.5 Biotez Berlin Recent Development
7.5 PerkinElmer
7.5.1 PerkinElmer Company Information
7.5.2 PerkinElmer Introduction and Business Overview
7.5.3 PerkinElmer Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 PerkinElmer Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.5.5 PerkinElmer Recent Development
7.6 VICAM
7.6.1 VICAM Company Information
7.6.2 VICAM Introduction and Business Overview
7.6.3 VICAM Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 VICAM Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.6.5 VICAM Recent Development
7.7 Ring Biotechnology
7.7.1 Ring Biotechnology Company Information
7.7.2 Ring Biotechnology Introduction and Business Overview
7.7.3 Ring Biotechnology Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ring Biotechnology Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.7.5 Ring Biotechnology Recent Development
7.8 R-Biopharm AG
7.8.1 R-Biopharm AG Company Information
7.8.2 R-Biopharm AG Introduction and Business Overview
7.8.3 R-Biopharm AG Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 R-Biopharm AG Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.8.5 R-Biopharm AG Recent Development
7.9 CHROMATIFIC
7.9.1 CHROMATIFIC Company Information
7.9.2 CHROMATIFIC Introduction and Business Overview
7.9.3 CHROMATIFIC Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 CHROMATIFIC Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.9.5 CHROMATIFIC Recent Development
7.10 Neogen
7.10.1 Neogen Company Information
7.10.2 Neogen Introduction and Business Overview
7.10.3 Neogen Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Neogen Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.10.5 Neogen Recent Development
7.11 Kwinbon Biotechnology
7.11.1 Kwinbon Biotechnology Company Information
7.11.2 Kwinbon Biotechnology Introduction and Business Overview
7.11.3 Kwinbon Biotechnology Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Kwinbon Biotechnology Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.11.5 Kwinbon Biotechnology Recent Development
7.12 Shandong Meizheng Bio-Tech
7.12.1 Shandong Meizheng Bio-Tech Company Information
7.12.2 Shandong Meizheng Bio-Tech Introduction and Business Overview
7.12.3 Shandong Meizheng Bio-Tech Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Shandong Meizheng Bio-Tech Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.12.5 Shandong Meizheng Bio-Tech Recent Development
7.13 Pribolab
7.13.1 Pribolab Company Information
7.13.2 Pribolab Introduction and Business Overview
7.13.3 Pribolab Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Pribolab Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.13.5 Pribolab Recent Development
7.14 Jiangsu Suwei Micro-Biology Research
7.14.1 Jiangsu Suwei Micro-Biology Research Company Information
7.14.2 Jiangsu Suwei Micro-Biology Research Introduction and Business Overview
7.14.3 Jiangsu Suwei Micro-Biology Research Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Jiangsu Suwei Micro-Biology Research Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.14.5 Jiangsu Suwei Micro-Biology Research Recent Development
7.15 Shandong Lvdu Bio-Sciences & Technology
7.15.1 Shandong Lvdu Bio-Sciences & Technology Company Information
7.15.2 Shandong Lvdu Bio-Sciences & Technology Introduction and Business Overview
7.15.3 Shandong Lvdu Bio-Sciences & Technology Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Shandong Lvdu Bio-Sciences & Technology Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.15.5 Shandong Lvdu Bio-Sciences & Technology Recent Development
7.16 Jiangsu Wisdom Engineering & Technology
7.16.1 Jiangsu Wisdom Engineering & Technology Company Information
7.16.2 Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
7.16.3 Jiangsu Wisdom Engineering & Technology Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Jiangsu Wisdom Engineering & Technology Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.16.5 Jiangsu Wisdom Engineering & Technology Recent Development
7.17 BIOCOMMA
7.17.1 BIOCOMMA Company Information
7.17.2 BIOCOMMA Introduction and Business Overview
7.17.3 BIOCOMMA Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 BIOCOMMA Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.17.5 BIOCOMMA Recent Development
7.18 Beijing Nano-Ace Technology
7.18.1 Beijing Nano-Ace Technology Company Information
7.18.2 Beijing Nano-Ace Technology Introduction and Business Overview
7.18.3 Beijing Nano-Ace Technology Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Beijing Nano-Ace Technology Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.18.5 Beijing Nano-Ace Technology Recent Development
7.19 Femdetection
7.19.1 Femdetection Company Information
7.19.2 Femdetection Introduction and Business Overview
7.19.3 Femdetection Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Femdetection Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.19.5 Femdetection Recent Development
7.20 Wuhan Huamei Wisherkon Biotech
7.20.1 Wuhan Huamei Wisherkon Biotech Company Information
7.20.2 Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
7.20.3 Wuhan Huamei Wisherkon Biotech Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Wuhan Huamei Wisherkon Biotech Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.20.5 Wuhan Huamei Wisherkon Biotech Recent Development
7.21 Changsha Huaxue Biological Technology
7.21.1 Changsha Huaxue Biological Technology Company Information
7.21.2 Changsha Huaxue Biological Technology Introduction and Business Overview
7.21.3 Changsha Huaxue Biological Technology Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Changsha Huaxue Biological Technology Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.21.5 Changsha Huaxue Biological Technology Recent Development
7.22 Anavo
7.22.1 Anavo Company Information
7.22.2 Anavo Introduction and Business Overview
7.22.3 Anavo Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Anavo Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.22.5 Anavo Recent Development
7.23 Shandong Vnya Bio-technology
7.23.1 Shandong Vnya Bio-technology Company Information
7.23.2 Shandong Vnya Bio-technology Introduction and Business Overview
7.23.3 Shandong Vnya Bio-technology Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Shandong Vnya Bio-technology Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.23.5 Shandong Vnya Bio-technology Recent Development
7.24 Guanyibio
7.24.1 Guanyibio Company Information
7.24.2 Guanyibio Introduction and Business Overview
7.24.3 Guanyibio Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.24.4 Guanyibio Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.24.5 Guanyibio Recent Development
7.25 Prufunglab
7.25.1 Prufunglab Company Information
7.25.2 Prufunglab Introduction and Business Overview
7.25.3 Prufunglab Ochratoxin Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.25.4 Prufunglab Ochratoxin Immunoaffinity Columns (IAC) Product Offerings
7.25.5 Prufunglab Recent Development
8 Industry Chain Analysis
8.1 Ochratoxin Immunoaffinity Columns (IAC) Industrial Chain
8.2 Ochratoxin Immunoaffinity Columns (IAC) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ochratoxin Immunoaffinity Columns (IAC) Sales Model
8.5.2 Sales Channel
8.5.3 Ochratoxin Immunoaffinity Columns (IAC) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Gold Standard Diagnostics Horsham
LCTech
Shimadzu
Biotez Berlin
PerkinElmer
VICAM
Ring Biotechnology
R-Biopharm AG
CHROMATIFIC
Neogen
Kwinbon Biotechnology
Shandong Meizheng Bio-Tech
Pribolab
Jiangsu Suwei Micro-Biology Research
Shandong Lvdu Bio-Sciences & Technology
Jiangsu Wisdom Engineering & Technology
BIOCOMMA
Beijing Nano-Ace Technology
Femdetection
Wuhan Huamei Wisherkon Biotech
Changsha Huaxue Biological Technology
Anavo
Shandong Vnya Bio-technology
Guanyibio
Prufunglab

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.